Magenta Therapeutics Inc share price logo

Magenta Therapeutics Inc Share Price

NASDAQ: DNTH

Small Cap

$38.87

+1.40

(+3.74%)

as on

Magenta Therapeutics Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $37.92
    $39.7
    downward going graph

    2.44%

    Downside

    2.14%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $13.37
    $39.7
    downward going graph

    65.62%

    Downside

    2.14%

    Upside

    downward going graph

Magenta Therapeutics Inc share price movements today

Previous Close
$37.47
Open
$38.23
Volume
538.3K
Day's Low - High
$37.92 - $39.7
52 Week Low - High
$13.37 - $39.7

Magenta Therapeutics Inc Historical Returns

1 Month Return
+ 85.5 %
3 Month Return
+ 122.94 %
1 Year Return
+ 49.54 %
3 Year Return
0 %
5 Year Return
0 %

Magenta Therapeutics Inc Stock Fundamentals & Key Indicators

Check Magenta Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.5B

EPS (TTM)

-3.4967

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-129.8M

Revenue (TTM)

4.9M

Profit Margin

0.00%

Return On Equity TTM

10038200.00%

Magenta Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Magenta Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Magenta Therapeutics Inc image
Magenta Therapeutics Inc
BUY$1.5BNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$60.5B248.74%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$38.7BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$99.3B45.88%27.5631.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$60.9B5.45%14.4931.37%

Stock Returns calculator for Magenta Therapeutics Inc Stock including INR - Dollar returns

The Magenta Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

Magenta Therapeutics Inc investment value today

Current value as on today

₹1,54,453

Returns

₹54,453

(+54.45%)

Returns from Magenta Therapeutics Inc Stock

₹49,500 (+49.5%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Magenta Therapeutics Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Magenta Therapeutics Inc. Average target price of $61.96

Magenta Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Magenta Therapeutics Inc.

What analysts predicted

37.27%UPSIDE

Target Price

$61.96

Current Price

$38.87

Analyzed by

12 Analysts

Target

$61.96

Magenta Therapeutics Inc target price $61.96, a slight upside of 37.27% compared to current price of $38.87. According to 12 analysts rating.

Magenta Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Magenta Therapeutics Inc Stock has increased by 680% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:680% versus previous 30 day period

Magenta Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
0
0
0
0
0
1
2
1
1
0
Gross Profit
0
0
0
0
0
1
2
1
1
0
Operating Income
-14
-5
-15
-12
-17
-22
-29
-31
-33
-34
EBITDA
-7
-11
-15
-12
-17
-22
-29
-31
-33
-34
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-29
-3
-14
-10
-13
-17
-25
-28
-29
-31
Income Tax Expense
1
0
-1
0
0
-
-
-
-
-
Net Income
-29
-3
-14
-10
-13
-17
-25
-28
-29
-31
Net Profit Margin
-6128.15%
-338.91%
-1597.73%
-2311.38%
-1573.00%
-945.09%
-1159.02%
-2144.80%
-2537.49%
-16388.08%

Magenta Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
1
6
2
6
Gross Profit
0
6
2
6
Operating Income
-74
-29
-48
-101
EBITDA
-69
-29
-47
-101
Interest Expense
3
-
-
-
Depreciation
-
0
0
0
Income Before Tax
-13
-28
-43
-84
Income Tax Expense
-1
-1
0
-
Net Income
-13
-28
-43
-84
Net Profit Margin
-888.14%
-443.76%
-1541.22%
-1362.77%

Magenta Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-3
-14
-10
-13
-17
-25
-28
-29
-31
Operating Cash Flow
-6
1
-11
-14
-14
-8
-27
-27
-23
Investing Cash Flow
18
-16
-8
-5
1
-259
-23
14
26
Financing Cash Flow
-
154
-4
217
-2
0
39
0
0
Change in Cash
12
94
-24
197
-15
-280
-10
-12
3

Magenta Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-35
-57
-76
-74
-13
-28
-43
-84
Operating Cash Flow
-22
-41
-57
-64
-59
-29
-36
-78
Investing Cash Flow
-2
-91
1
-10
43
-59
20
-286
Financing Cash Flow
71
142
62
67
89
96
133
255
Change in Cash
47
6
6
-6
73
-116
116
-109

Insights on Magenta Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, DNTH stock has moved up by 85.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 18.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 66.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 2.17M → 193.0K (in $), with an average decrease of 44.9% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 7 quarters, -10.56M → -31.62M (in $), with an average decrease of 20.9% per quarter

About Magenta Therapeutics Inc

magenta therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based diseases. by creating a platform focused on key areas of transplant medicine, magenta therapeutics is pioneering an integrated, but modular approach to stem cell therapies that reboot the blood and immune systems to create patient benefit. founded by internationally recognized leaders in stem cell transplant medicine, magenta therapeutics was launched in 2016 by third rock ventures and atlas venture and is headquartered in cambridge, mass. for more information, please visit www.magentatx.com.
OrganisationMagenta Therapeutics Inc
Headquarters7 Times Square, New York, NY, United States, 10036
CEOMr. Marino Garcia M.B.A.
E-voting on sharesClick here to vote

Key Management of Magenta Therapeutics Inc

Name

Title

Ms. Kristina Maximenko

Chief People Officer

Mr. Scott Nogi M.B.A.

Head of Business Operations

Ms. Debra Segal

Head of Regulatory Affairs

Mr. Marino Garcia M.B.A.

President, CEO & Director

Mr. Ryan Savitz

Chief Financial Officer & Chief Business Officer

Mr. Simrat Randhawa M.B.A., M.D.

Chief Medical Officer

Mr. Judson Taylor

Senior VP & Head of Technical Operations

Mr. Adam M. Veness Esq.

Senior VP, General Counsel & Secretary

Mr. Edward G. Carr

Chief Accounting Officer

Ms. Rashieda Gluck

Head of Clinical Development Operations

FAQs

What is Magenta Therapeutics Inc share price today?

Magenta Therapeutics Inc share price today is $38.87 as on at the close of the market. Magenta Therapeutics Inc share today touched a day high of $39.7 and a low of $37.92.

What is the 52 week high and 52 week low for Magenta Therapeutics Inc share?

Magenta Therapeutics Inc share touched a 52 week high of $39.7 on and a 52 week low of $13.37 on . Magenta Therapeutics Inc stock price today i.e. is closed at $38.87,which is 2.09% down from its 52 week high and 190.83% up from its 52 week low.

What is Magenta Therapeutics Inc's market capitalisation today?

Magenta Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Magenta Therapeutics Inc Stock (DNTH) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Magenta Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Magenta Therapeutics Inc Shares that will get you 0.0386 shares as per Magenta Therapeutics Inc share price of $38.87 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Magenta Therapeutics Inc Stock (DNTH) from India?

Indian investors can start investing in Magenta Therapeutics Inc (DNTH) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Magenta Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Magenta Therapeutics Inc share’s latest price of $38.87 as on September 18, 2025 at 1:29 am IST, you will get 0.2573 shares of Magenta Therapeutics Inc. Learn more about fractional shares .